Venator Capital Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
GIPM
DCM
AC
Venator Capital Management's OPRX Position: Q2 2022 in Review
Venator Capital Management sold out of OptimizeRx (OPRX) in Q2 2022, closing a stake of 50,000 shares — an estimated $1.89M sold.
Venator Capital Management first reported a position in OPRX in Q2 2018 and held it in 15 quarters. The position peaked at $17.3M in Q3 2021. 146 funds tracked by Wall St. Rank hold OPRX as of Q2 2022.
- Venator Capital Management reported no remaining OptimizeRx position as of Q2 2022 after selling out during the quarter.
- Venator Capital Management sold 50,000 OptimizeRx shares in Q2 2022, an estimated $1.89M.
- Venator Capital Management first reported a position in OptimizeRx in Q2 2018 and held it in 15 quarters.
- Venator Capital Management's OptimizeRx position peaked at $17.3M in Q3 2021.
- 146 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2022.
Based on Venator Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.